Abbott (NYSE:ABT) and Cardiovascular Systems, Inc. (CSI), today announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease. Under terms of the agreement, CSI stockholders will receive $20 per common share at a total expected equity value of approximately $890 million.
BMO Capital Maintains Market Perform on Synaptics, Raises Price Target to $135
BMO Capital analyst Ambrish Srivastava maintains Synaptics (NASDAQ:SYNA) with a Market Perform and raises the price target from $90 to $135.
